One third of hospital costs for atherothrombotic disease are attributable to readmissions: a linked data analysis
- PMID: 25102911
- PMCID: PMC4251605
- DOI: 10.1186/1472-6963-14-338
One third of hospital costs for atherothrombotic disease are attributable to readmissions: a linked data analysis
Abstract
Background: Cardiovascular disease is the most frequent cause of death in Australia, with an associated cost burden of 11% of Australian annual health expenditure of which 40% is for hospital admissions. We investigated health outcomes and the components of hospital expenditure in the two years after an atherothrombotic disease admission to a tertiary hospital in an Australian setting.
Methods: Using data linkage we analysed two years of hospitalisation data and death records of all men and women aged 35-84 years with an admission to a Western Australian tertiary hospital for atherothrombotic disease in 2007. Costs were identified by matching the Australian refined diagnostic related group on the admission records to the published schedules of public and private hospital costs for the period of interest, and converted to 2013 Australian dollars.
Results: Of 6172 patients studied (74% coronary, 20% cerebrovascular, 6% peripheral), 783 (13%) died during follow-up and 174 of these were in hospital case-fatalities at index. Thirty-two percent of patients (n = 1965) accounted for 3172 readmissions to hospital with one in three having multiple hospitalisations. The hazard ratio of atherothrombotic disease readmission was 1.45 (95% CI 1.27, 1.66) in those with more than one vascular territory affected compared to those with only one territory affected after controlling for age, sex, comorbidity, admission type, procedures, and episode length of stay. The total index plus 2-year admission cost for atherothrombotic disease was calculated at $101 million; $71 million for index, and $30 million for readmissions.
Conclusions: Among patients hospitalised with atherothrombotic disease, the cost of related rehospitalisations within 24 months is almost a third of the total. Much of the readmission costs fell within the first year. Whether readmissions and cost associated with atherothrombotic disease can be lowered through secondary prevention measures requires further investigation.
Figures


Similar articles
-
The economic implications of treating atherothrombotic disease in Australia, from the government perspective.Clin Ther. 2010 Jan;32(1):119-32; discussion 106-7. doi: 10.1016/j.clinthera.2010.01.009. Clin Ther. 2010. PMID: 20171418
-
Hospitalisations, admission costs and re-fracture risk related to osteoporosis in Western Australia are substantial: a 10-year review.Aust N Z J Public Health. 2015 Dec;39(6):557-62. doi: 10.1111/1753-6405.12381. Epub 2015 Jun 11. Aust N Z J Public Health. 2015. PMID: 26095668
-
Downward trend in the prevalence of hospitalisation for atherothrombotic disease.Int J Cardiol. 2013 Apr 5;164(2):185-92. doi: 10.1016/j.ijcard.2011.06.122. Epub 2011 Jul 23. Int J Cardiol. 2013. PMID: 21782259
-
Long-Term Pattern and Associated Costs of Re-hospitalisations in Patients After Index Atrial Fibrillation Admission in Western Australia, 2011-2017.Heart Lung Circ. 2024 Jan;33(1):55-64. doi: 10.1016/j.hlc.2023.12.004. Epub 2023 Dec 29. Heart Lung Circ. 2024. PMID: 38160127
-
Hospital costs for unplanned re-admissions within 30 days of hospitalisations with heart failure, Australia, 2013-2017: a retrospective cohort study.Med J Aust. 2024 Sep 16;221(6):317-323. doi: 10.5694/mja2.52424. Epub 2024 Aug 27. Med J Aust. 2024. PMID: 39188208
Cited by
-
QUality improvement in primary care to prevent hospitalisations and improve Effectiveness and efficiency of care for people Living with coronary heart disease (QUEL): protocol for a 24-month cluster randomised controlled trial in primary care.BMC Fam Pract. 2020 Feb 14;21(1):36. doi: 10.1186/s12875-020-01105-0. BMC Fam Pract. 2020. PMID: 32059641 Free PMC article.
-
Design and rationale of the MyHeartMate study: a randomised controlled trial of a game-based app to promote behaviour change in patients with cardiovascular disease.BMJ Open. 2019 May 14;9(5):e024269. doi: 10.1136/bmjopen-2018-024269. BMJ Open. 2019. PMID: 31092643 Free PMC article.
-
Mobile Technology Use Across Age Groups in Patients Eligible for Cardiac Rehabilitation: Survey Study.JMIR Mhealth Uhealth. 2017 Oct 24;5(10):e161. doi: 10.2196/mhealth.8352. JMIR Mhealth Uhealth. 2017. PMID: 29066425 Free PMC article.
-
The Economic Implications of Introducing Single-Patient ECG Systems for Cardiac Surgery in Australia.Clinicoecon Outcomes Res. 2021 Aug 13;13:727-735. doi: 10.2147/CEOR.S325257. eCollection 2021. Clinicoecon Outcomes Res. 2021. PMID: 34413659 Free PMC article.
-
Initial Implementation of the My Heart, My Life Program by the National Heart Foundation of Australia: Pilot Mixed Methods Evaluation Study.JMIR Cardio. 2023 Oct 5;7:e43889. doi: 10.2196/43889. JMIR Cardio. 2023. PMID: 37796544 Free PMC article.
References
-
- Australian Institute of Health and Welfare . Cardiovascular Disease: Australian Facts 2011 [Internet] 2011. Volume AIHW cat. no. CVD 53.
-
- Australian Institute of Health and Welfare . Health expenditure Australia 2010–11. Canberra: AIHW; 2012. Volume Cat. no. HWE 56.
-
- Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, Halperin JL, Johnston SC, Katzan I, Kernan WN, Mitchell PH, Ovbiagele B, Palesch YY, Sacco RL, Schwamm LH, Wasserthiel-Smoller S, Turan TN, Wentworth D, on behalf of the American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Care and Outcomes Research Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack. Stroke. 2011;42(1):227–276. doi: 10.1161/STR.0b013e3181f7d043. - DOI - PubMed
-
- Norman PE, Eikelboom JW, Hankey GJ. Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications. Med J Aust. 2004;181(3):150–154. - PubMed
Pre-publication history
-
- The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1472-6963/14/338/prepub
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical